ISHLT 39th Annual Meeting & Scientific Sessions (Pharmacists)
How would you like your name to appear on your certificate?
Profession
Select Your Profession
Other
Pharmacist
Next
How many credit hours did you complete?
Credit Hours (maximum: 26.25)
Agreement
By completing this form, you attest that you have attended the number of hours you have indicated above.
I agree
Previous
Next
Was the educational content of value to you?
Very Valuable
Average
Waste of time
Previous
Next
Was the educational content scientifically sound?
Yes
No
If no, please explain...
Previous
Next
Did you perceive any commercial bias or influence in the educational content?
Yes
No
If yes, please explain...
Previous
Next
After attending the Annual Meeting, were the following educational objectives met?
Discuss the latest information and approaches regarding transplant research, surgical techniques, medical therapies, donor management, and patient management for the treatment of patients suffering from end stage heart and lung disease.
Yes
No
Discuss the state-of-the-art treatment approaches, risk factors, risk management approaches, patient selection criteria, disease prevention strategies, outcome implications, and psychosocial management strategies for patients with end stage heart and lung failure.
Yes
No
Discuss the areas of emerging technologies, medical advances, and the clinical applications of basic science models of end stage heart and lung disease management and prevention.
Yes
No
If not, why not...
Previous
Next
Do you think what you learned will benefit you in your practice?
If yes, how...
Previous
Next
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924:
Previous
Next
Tell us what was good or bad about the content of this educational activity (i.e. slides, materials, speakers).
Previous
Next
What topics would you like to see addressed in future meetings?
Previous
Next
Additional Comments:
Previous